FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308187421> ?p ?o ?g. }

• W4308187421 endingPage "3445" @default.
• W4308187421 startingPage "3428" @default.
• W4308187421 abstract "Imbalances in dopamine levels result in neurological and psychological disorders such as elevated dopamine in Parkinson's disease.Despite a considerable number of advertisements claiming Aloe-vera's effectiveness in PD treatment, it has hidden long-term disadvantages for healthy people and PD patients.In the present investigation, the impacts of Aloe-vera on dopaminergic cells were evaluated.The results indicated that the focal adhesion kinase (FAK) enhancement was in line with the Bax/Bcl2 ratio decrement, reactive oxygen specious (ROS) production, and nonsignificant alteration in the sub-G1phase of the cell cycle. It led to glial cell-derived neurotrophic factor (GDNF) upregulation but did not significantly change the BDNF level involved in depression and motor impairment recovery. These events apparently resulted in the enhancement in dopaminergic cell viability and neurite length and attenuated PI+ cells. However, it also induced neuronal nitric oxide synthase (nNOS) overexpression and nitric oxide (NO) and lactate dehydrogenase (LDH) production. Notably, docking results of the catalytic domain in tyrosine hydroxylase (TH) with the Aloe-vera constituents showed strong binding of most Aloe-vera constituents with the catalytic domain of TH, even stronger than L-tyrosine as an original substrate. Following the docking results, Aloe-vera downregulated TH protein and attenuated dopamine.It can be hypothesized that Aloe-vera improves PD symptoms through enhancement in antiapoptotic markers and neurotrophic factors, while it suppresses TH and dopamine in the form of a Trojan horse, later resulting in the future deterioration of the disease symptoms. The results provide cues to pharmaceutical companies to use the active components of Aloe-vera as putative agents in neurological and psychiatric disorders and diseases to decrease dopamine in patients with enhanced dopamine levels." @default.
• W4308187421 created "2022-11-09" @default.
• W4308187421 creator A5007424003 @default.
• W4308187421 creator A5014314929 @default.
• W4308187421 creator A5015112814 @default.
• W4308187421 creator A5017331923 @default.
• W4308187421 creator A5049081181 @default.
• W4308187421 creator A5056853675 @default.
• W4308187421 creator A5061185262 @default.
• W4308187421 creator A5063245159 @default.
• W4308187421 date "2022-11-01" @default.
• W4308187421 modified "2023-09-29" @default.
• W4308187421 title "Strong Binding of Phytochemicals to the Catalytic Domain of Tyrosine Hydroxylase as a Trojan Horse Decreases Dopamine in Dopaminergic Cells: Pharmaceutical Considerations in Schizophrenia and Parkinson’s Disease" @default.
• W4308187421 cites W1549872256 @default.
• W4308187421 cites W1598408991 @default.
• W4308187421 cites W1835101323 @default.
• W4308187421 cites W1866745427 @default.
• W4308187421 cites W1967075670 @default.
• W4308187421 cites W1976769213 @default.
• W4308187421 cites W1993888368 @default.
• W4308187421 cites W2005542341 @default.
• W4308187421 cites W2008518508 @default.
• W4308187421 cites W2014850190 @default.
• W4308187421 cites W2016445640 @default.
• W4308187421 cites W2034037367 @default.
• W4308187421 cites W2037052204 @default.
• W4308187421 cites W2040018169 @default.
• W4308187421 cites W2043713606 @default.
• W4308187421 cites W2054283723 @default.
• W4308187421 cites W2057570450 @default.
• W4308187421 cites W2078688897 @default.
• W4308187421 cites W2085227738 @default.
• W4308187421 cites W2086919585 @default.
• W4308187421 cites W2092310066 @default.
• W4308187421 cites W2097993004 @default.
• W4308187421 cites W2106384108 @default.
• W4308187421 cites W2108384603 @default.
• W4308187421 cites W2109074960 @default.
• W4308187421 cites W2113651938 @default.
• W4308187421 cites W2118225178 @default.
• W4308187421 cites W2120708056 @default.
• W4308187421 cites W2131208794 @default.
• W4308187421 cites W2133095097 @default.
• W4308187421 cites W2139495058 @default.
• W4308187421 cites W2160324065 @default.
• W4308187421 cites W2167437003 @default.
• W4308187421 cites W2168828935 @default.
• W4308187421 cites W2170408157 @default.
• W4308187421 cites W2226762295 @default.
• W4308187421 cites W2273032085 @default.
• W4308187421 cites W2299212290 @default.
• W4308187421 cites W2299681973 @default.
• W4308187421 cites W2325828773 @default.
• W4308187421 cites W2347035466 @default.
• W4308187421 cites W2407313751 @default.
• W4308187421 cites W2410800688 @default.
• W4308187421 cites W2411519439 @default.
• W4308187421 cites W2415368356 @default.
• W4308187421 cites W2418775906 @default.
• W4308187421 cites W2466076814 @default.
• W4308187421 cites W2581745073 @default.
• W4308187421 cites W2582745502 @default.
• W4308187421 cites W2603275961 @default.
• W4308187421 cites W2614937263 @default.
• W4308187421 cites W2625798919 @default.
• W4308187421 cites W2795334944 @default.
• W4308187421 cites W2889039154 @default.
• W4308187421 cites W2909894160 @default.
• W4308187421 cites W2910797940 @default.
• W4308187421 cites W2922448793 @default.
• W4308187421 cites W2997108244 @default.
• W4308187421 cites W3188628968 @default.
• W4308187421 cites W4292992147 @default.
• W4308187421 cites W4298281742 @default.
• W4308187421 cites W585380073 @default.
• W4308187421 cites W1859573820 @default.
• W4308187421 doi "https://doi.org/10.2174/1381612829666221102151926" @default.
• W4308187421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36330626" @default.
• W4308187421 hasPublicationYear "2022" @default.
• W4308187421 type Work @default.
• W4308187421 citedByCount "2" @default.
• W4308187421 countsByYear W43081874212023 @default.
• W4308187421 crossrefType "journal-article" @default.
• W4308187421 hasAuthorship W4308187421A5007424003 @default.
• W4308187421 hasAuthorship W4308187421A5014314929 @default.
• W4308187421 hasAuthorship W4308187421A5015112814 @default.
• W4308187421 hasAuthorship W4308187421A5017331923 @default.
• W4308187421 hasAuthorship W4308187421A5049081181 @default.
• W4308187421 hasAuthorship W4308187421A5056853675 @default.
• W4308187421 hasAuthorship W4308187421A5061185262 @default.
• W4308187421 hasAuthorship W4308187421A5063245159 @default.
• W4308187421 hasConcept C113246987 @default.
• W4308187421 hasConcept C126322002 @default.
• W4308187421 hasConcept C134018914 @default.
• W4308187421 hasConcept C137183658 @default.
• W4308187421 hasConcept C159167319 @default.
• W4308187421 hasConcept C160539049 @default.
• W4308187421 hasConcept C170493617 @default.

• next